GlassScriptPhysician profile
Mohanad Hasan
NPI 1467794008
$24,869.20
in general payments reported to CMS, 2019-2025
28 companies · $4,657 in 2025
The $4,657 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $1,619 · 2021: $1,840 · 2022: $8,353 · 2023: $4,117 · 2024: $3,721 · 2025: $4,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,395 · Travel and Lodging: $4,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,394.50 |
| Travel and Lodging | $4,100.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $6,359.71 | 2020-2025 | Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $6,266.66 | 2021-2025 | Triclip, Perclose Prostyle, Mitraclip |
| Penumbra, INC. | $3,070.73 | 2021-2023 | Indigo System |
| Abiomed | $2,182.78 | 2021-2025 | Impella |
| Boston Scientific Corporation | $2,051.49 | 2019-2025 | Watchman Flx, Watchman Access System, General - Atherectomy |
| Medtronic, INC. | $1,594.44 | 2021-2025 | Corevalve Evolut R, Micra, Abre |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $586.49 | 2020-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $431.37 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $410.56 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $308.10 | 2020-2025 | Camzyos, Eliquis |
| Pfizer INC. | $170.75 | 2020-2023 | |
| Livanova USA, INC. | $154.84 | 2019-2020 | |
| Shockwave Medical, INC | $149.98 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astellas Pharma US INC | $144.62 | 2021 | |
| Heartflow, INC. | $139.82 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $137.34 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $135.98 | 2021-2022 | |
| Amgen INC. | $113.87 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $108.72 | 2020 | |
| Cardiovascular Systems INC. | $107.80 | 2020 | |
| Novo Nordisk INC | $68.00 | 2023-2024 | Ozempic, Wegovy |
| Biosense Webster, INC. | $35.41 | 2025 | Nuvision Ice Catheter |
| Angiodynamics, INC. | $31.82 | 2024 | Alphavac |
| Esperion Therapeutics, INC. | $29.17 | 2025 | Nexletol |
| Kestra Medical Technology Services, INC. | $24.36 | 2023 | Assure Wcd |
| Inspire Medical Systems, INC. | $23.83 | 2024 | Inspire |
| Asahi Intecc USA, INC. | $21.82 | 2025 | Asahi Peripheral Vascular Wires |
| Acutus Medical, INC. | $8.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohanad Hasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.